Salient Pharma ApS Financials, key figures and credit report
Gross profit - 129.9 kDKK FY 2025 -4.4% vs 2024
EBIT - 129.9 kDKK FY 2025 -4.4% vs 2024
Net debt 1 306.4 kDKK FY 2025 +27.7% vs 2024
Quick ratio 0.0 FY 2025 +0 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | - 261.31 | - 125.51 | - 233.31 | - 124.37 | - 129.89 |
| EBIT | - 261.31 | - 125.51 | - 233.31 | - 124.37 | - 129.89 |
| Other financial expenses | -39.95 | -62.65 | -71.62 | -77.81 | -88.46 |
| Pre-tax profit | - 301.26 | - 188.16 | - 304.93 | - 202.18 | - 218.34 |
| Net earnings | - 301.26 | - 188.16 | - 304.93 | - 202.18 | - 218.34 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Raw materials and consumables | 12.65 | 12.65 | |||
| Finished products/goods | 12.16 | 11.46 | |||
| Inventories total | 12.16 | 11.46 | 12.65 | 12.65 | |
| Current trade debtors | 3.46 | ||||
| Current other receivables | 17.81 | 17.59 | 12.28 | -11.56 | 21.61 |
| Short term receivables total | 17.81 | 17.59 | 15.73 | -11.56 | 21.61 |
| Cash and bank deposits | 24.93 | 28.96 | 4.89 | 17.94 | 10.27 |
| Cash and cash equivalents | 24.93 | 28.96 | 4.89 | 17.94 | 10.27 |
| Balance sheet total (assets) | 54.90 | 58.01 | 20.62 | 19.02 | 44.53 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 57.12 | 57.12 | 182.66 | 419.92 | 419.92 |
| Retained earnings | - 549.06 | - 850.32 | -1 038.48 | -1 343.40 | -1 545.59 |
| Profit of the financial year | - 301.26 | - 188.16 | - 304.93 | - 202.18 | - 218.34 |
| Shareholders equity total | - 793.20 | - 981.37 | -1 160.74 | -1 125.66 | -1 344.01 |
| Non-current liabilities total | |||||
| Advances received | 3.41 | 3.41 | |||
| Current trade creditors | 162.55 | 147.02 | 217.62 | 100.44 | 68.44 |
| Current owed to participating | 680.09 | 892.36 | 963.74 | 1 040.84 | 1 316.69 |
| Other non-interest bearing current liabilities | 5.46 | ||||
| Current liabilities total | 848.10 | 1 039.37 | 1 181.37 | 1 144.69 | 1 388.54 |
| Balance sheet total (liabilities) | 54.90 | 58.01 | 20.62 | 19.02 | 44.53 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated